GeneHealth - Your precision medicine

Thyroiditis Subacute

Disease Details

Family Health Simplified

Buy Membership

Description: Subacute thyroiditis is an inflammatory condition of the thyroid gland often triggered by a viral infection, characterized by painful swelling and temporary hyperthyroidism.
Type: Subacute thyroiditis is a type of thyroid inflammation. It is generally not considered to have a primary genetic transmission. Instead, it is often associated with viral infections, which may trigger the condition.
Signs And Symptoms: Subacute thyroiditis, also known as De Quervain's thyroiditis, is characterized by the following signs and symptoms:

1. **Pain and Tenderness**: Pain in the neck, particularly at the site of the thyroid gland, which may radiate to the jaw or ears.
2. **Fever**: Low-grade fever.
3. **Fatigue**: General feeling of tiredness and malaise.
4. **Thyroid Function Fluctuations**: Periods of hyperthyroidism (excess thyroid hormone) followed by hypothyroidism (insufficient thyroid hormone).
5. **Thyroid Enlargement**: Swelling of the thyroid gland.
6. **Difficulty Swallowing**: Sometimes pain while swallowing or discomfort in the throat.

Other symptoms might include muscle aches and a general feeling of being ill.
Prognosis: Subacute thyroiditis, also known as De Quervain's thyroiditis, typically has a good prognosis. Most patients recover fully within a few months to a year. During the illness, patients experience phases of hyperthyroidism followed by hypothyroidism before eventually returning to normal thyroid function. In rare cases, some individuals may develop permanent hypothyroidism and require lifelong thyroid hormone replacement therapy. Treatment primarily involves managing symptoms with anti-inflammatory medications, such as NSAIDs or corticosteroids, and beta-blockers if needed for hyperthyroid symptoms. Regular follow-up with a healthcare provider is important to monitor thyroid function.
Onset: Subacute thyroiditis typically has a sudden onset, often presenting with pain in the anterior neck that may radiate to the jaw or ears. This condition often follows a recent viral infection.
Prevalence: The prevalence of subacute thyroiditis is relatively rare, affecting about 12 in 100,000 people per year. It is more common in women than in men, usually occurring in middle-aged individuals.
Epidemiology: Subacute thyroiditis, also known as De Quervain's thyroiditis, is an inflammatory condition of the thyroid that is believed to have a viral etiology. It typically occurs more frequently in women than in men, with a female-to-male ratio of about 4:1. The condition is most commonly seen in middle-aged adults, usually between the ages of 40 and 50. The incidence of subacute thyroiditis is relatively low compared to other thyroid disorders, but detailed epidemiological data is sparse. It often presents following upper respiratory tract infections and may show a seasonal pattern, peaking in the summer and early autumn.
Intractability: Subacute thyroiditis is generally not considered intractable. It often resolves on its own or responds well to treatment, which can include medications like nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids to manage inflammation and pain. Most patients recover fully, although some may experience temporary thyroid dysfunction.
Disease Severity: - Disease severity: Moderate to severe, often characterized by neck pain, fever, and malaise. It can lead to temporary hyperthyroidism followed by hypothyroidism before returning to normal function.
Healthcare Professionals: Disease Ontology ID - DOID:7165
Pathophysiology: Subacute thyroiditis, also known as De Quervain’s thyroiditis, typically involves inflammation of the thyroid gland, often following a viral infection. The pathophysiology includes the destruction of thyroid follicular cells, leading to the release of stored thyroid hormones (thyrotoxicosis), followed by a phase of hypothyroidism as the hormone stores are depleted. This is usually a temporary condition, and the thyroid often recovers normal function over time. The inflammation may cause pain in the thyroid region, extending to the jaw or ears, and systemic symptoms like fever and fatigue.
Carrier Status: Subacute thyroiditis is not associated with a carrier status because it is a condition involving inflammation of the thyroid gland, often triggered by a viral infection, rather than a genetic or inherited disease. It typically presents with symptoms such as neck pain, fever, and transient hyperthyroidism followed by hypothyroidism.
Mechanism: Subacute thyroiditis, also known as De Quervain's thyroiditis, involves inflammation of the thyroid gland that usually follows a viral infection. The mechanism includes an initial viral infection that triggers an immune response, leading to inflammation and thyroid tissue damage.

Molecular mechanisms underlying subacute thyroiditis include:

1. **Immune Response**: Following the viral infection, immune cells such as T-lymphocytes infiltrate the thyroid gland, releasing cytokines that mediate inflammation and tissue damage.

2. **Cytokine Release**: Pro-inflammatory cytokines like IL-1, IL-6, and TNF-alpha are released, contributing to the local inflammation and systemic symptoms such as fever and malaise.

3. **Cell-Mediated Cytotoxicity**: Cytotoxic T-cells attack thyroid follicular cells, causing cell death and release of stored thyroid hormones (T3 and T4) into the bloodstream, leading to transient thyrotoxicosis.

4. **Apoptosis**: The inflammatory process can induce apoptosis (programmed cell death) in thyroid cells, further contributing to the release of thyroid hormones and subsequent hypothyroidism as the inflammation resolves and the gland is temporarily less functional.

5. **Viral Molecular Mimicry**: Sometimes, viral proteins mimic thyroid antigens, leading to an immune response that cross-reacts with thyroid tissue, perpetuating the inflammatory process.

Understanding these molecular mechanisms is crucial for diagnosing and managing subacute thyroiditis effectively.
Treatment: Treatment for subacute thyroiditis (also known as De Quervain's thyroiditis) typically focuses on managing symptoms and may include:

1. **Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)**: To reduce pain and inflammation.
2. **Corticosteroids**: For more severe pain and inflammation that do not respond to NSAIDs.
3. **Beta-Blockers**: To manage symptoms of hyperthyroidism, such as palpitations and anxiety.
4. **Thyroid Hormone Replacement**: If the thyroid gland becomes underactive (hypothyroid phase) and the patient experiences significant symptoms, temporary thyroid hormone replacement may be needed.

Regular monitoring of thyroid function tests is important to adjust treatments as the disease progresses. The condition often resolves on its own over time.
Compassionate Use Treatment: Compassionate use or off-label treatments for subacute thyroiditis may include:

1. **Corticosteroids**: While not the first-line treatment, corticosteroids, such as prednisone, can be used off-label to reduce inflammation and manage severe symptoms, especially when NSAIDs (nonsteroidal anti-inflammatory drugs) are insufficient.
2. **Beta-blockers**: Off-label use to manage symptoms of hyperthyroidism, like palpitations and anxiety, which can occur in the initial phase of subacute thyroiditis.
3. **Antithyroid drugs**: These are rarely used but can be considered off-label in cases where hyperthyroidism is severe and symptomatic.

Experimental or compassionate use treatments are less common for subacute thyroiditis due to its usually self-limiting nature and effectiveness of standard therapies.
Lifestyle Recommendations: Lifestyle recommendations for managing subacute thyroiditis include:

1. **Rest**: Ensuring adequate rest is crucial to help your body recover.
2. **Hydration**: Drink plenty of fluids to stay hydrated.
3. **Balanced Diet**: Maintain a healthy diet rich in vegetables, fruits, lean proteins, and whole grains.
4. **Avoid Strain**: Limit physical activities that may strain your neck or thyroid region.
5. **Medication Adherence**: Follow prescribed medication regimens strictly, including anti-inflammatory drugs if advised by your doctor.
6. **Regular Monitoring**: Keep up with regular medical appointments to monitor thyroid hormone levels and adjust treatments as necessary.
7. **Stress Reduction**: Practice stress-reduction techniques such as yoga, meditation, or deep-breathing exercises.

No specific information was found for "nan."
Medication: Subacute thyroiditis, also known as de Quervain's thyroiditis, is often treated with nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. In more severe cases, corticosteroids like prednisone may be prescribed. Sometimes beta-blockers are used to manage symptoms of hyperthyroidism if they occur.
Repurposable Drugs: Information on repurposable drugs for subacute thyroiditis (also known as de Quervain's thyroiditis) is not typically specified as such in medical literature. However, treatment often involves the use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen to reduce inflammation and pain. In more severe cases, corticosteroids such as prednisone may be prescribed. These medications are commonly used for other inflammatory conditions and may be considered repurposable in the context of treating subacute thyroiditis.
Metabolites: Subacute thyroiditis, also known as De Quervain's thyroiditis, is associated with certain metabolites. Commonly elevated metabolites may include:

1. **Thyroglobulin**: This protein is often elevated due to thyroid inflammation and tissue disruption.
2. **Thyroid Hormones**: Both thyroxine (T4) and triiodothyronine (T3) can be elevated initially during the hyperthyroid phase of subacute thyroiditis.
3. **Inflammatory Markers**: Markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are typically elevated, indicating inflammation.

It is important to note these metabolites for a comprehensive understanding and diagnosis of subacute thyroiditis.
Nutraceuticals: There is no specific nutraceutical regimen established for the treatment of subacute thyroiditis. Management primarily focuses on controlling inflammation and pain, usually with nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids. Always consult with a healthcare provider for personalized advice.
Peptides: For subacute thyroiditis, there are no specific therapeutic peptides widely recognized or used in clinical practice for this condition. The management primarily involves anti-inflammatory medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, to reduce inflammation and alleviate symptoms. The use of peptides in this context has not been established or commonly referenced in the treatment protocols.